NFKK 2014

Wednesday September 17


Breakfast seminar:
Beckman Coulter AB - 
Room: F1

Beckman Coulter’s Innovative Approach to Automating Clinical Molecular Diagnostics

Speaker: Brendan McKeown, PhD, Senior Molecular Applications Specialist, UK


Morning Plenary session - Room: F3

Chair: Ola Hammarsten

Future biomarkers in acute coronary syndromes. (201)

Bertil Lindahl,Sweden


Coffee and exhibition in the exhibition and poster area


Room: F1

Biomarkers for future risk of cardiovascular disease

Our ability to use biomarkers to predict the development of cardiovascular disease in a healthy person, as a foundation for primary prevention, is currently less than perfect. This session will discuss approaches to finding new biomarkers that may be used for primary and secondary prevention

Chairs: Ola Hammarsten and Christian Löwbeer

10:15 - 10:45 Endocrine and metabolic risk factors for cardiometabolic disease (202)
Olle Melander, Sweden

10:45 - 11:15 Novel and established kidney disease biomarkers in the prediction of cardiovascular disease (203)
Johan Ärnlöv, Sweden

11:15 - 11:45 Risk prediction of cardio-vascular disease by high sensitive cardiac troponin assays (204)
Per Venge, Sweden

11:45 - 12:00 Integrated Targeted Quantitation Method for Insulin and its Therapeutic Analogs (205)
Ravindra, Chaudhari, United States

Room: F2

Laboratory Point Of Care Testing - current and future challenges

Small and locally available laboratory equipment gives the physician convenient and immediate access to test results. However, as the tests are often performed by untrained personnel, the test quality is often a problem. This session will discuss the current and future challenges in the quality control of Point Of Care Testing

Chair: Anne-Charlotte Wicktorsson

10:15-10:25 Introduction

10:25-10:55 Patient safety – the value of SKUP evaluations of point of care instruments (206)
Elisabeth Eriksson Boija, Sweden

10:55-11:25 Quality assurance of the pre- and post analytical phase (207)
Sverre Sandberg,Norway.

11:25-11:55 Accreditation of Point Of Care Testing, POCT, at Sahlgrenska University Hospital according to ISO 22870:2006 (208)
Birgitta Kallberg,Sweden

11:55-12:00 Summary

Room: F3

Novel laboratory technology - the single molecule era

Nanotechnology and other techniques now allow reliable single molecule detection that can be implemented in routine analysis. This session will cover the challenges and opportunities that this novel technology will bring to the clinical laboratories.

Chairs: Julia Asp andGöran Larson

10:15 - 10:45Analyzing biology cell by cell and molecule by molecule (209)
Ulf Landegren and Masood Kamali-Moghaddam

10:45 - 11:15 High throughput single cell expression profiling and characterization of circulating tumor cells (210)
Mikael Kubista, Sweden

11:15 - 11:40 A translational equine approach towards development of human biomarkers of early osteoarthritis (211)
Anders Lindahl, Sweden

11:40 - 11:50 Establishment of a GC-MS/MS methodology for comprehensive sex steroid profiling in mouse serum (212)
Maria Nilsson, Sweden

11:50 -12:00 Development and application of an LC-MS method with high resolution accurate masses detection (HRAM) with ExactivePlus mass spectrometer and online sample preparation (213)
Valérie Thibert, France


Lunch - Exhibition and lunch seminars


Lunch seminar:

Abbott Scandinavia AB - Room: F1

Chairperson: Dave Ambruster, Director, Global Scientific Affairs, Abbott Diagnostics

Real life experiences of new assays. HbA1c multicentre study- what do the results tell us.

Speaker: Johannes Lotz, Institute for Laboratory Medicine, University Hospital Mainz, Germany

Our experience with High Sensitive Troponin

Speaker: Clare Ford, The Royal Wolverhampton NHS Trust, New Cross Hospital , UK

Siemens Healthcare Diagnostics - Room: F2

Elf in Liver Fibrosis

Speaker: Professor W M C Rosenberg MA, MBBS, DPhil, FRCP, UCL Institute for Liver & Digestive Health, University College London


Afternoon Plenary Session - Room: F3

Surface-based single-liposome sensing for diagnostics and drug screening applications (214)

Chair: Göran Larson

Fredrik Höök,Sweden


Coffee and exhibition in the exhibition and poster area


Room: F1

Novel diagnostic biomarkers in cardiology

A large proportion of patients seeking health care have cardiac disease that often can be treated efficiently if correctly diagnosed. This session will discuss novel diagnostic biomarkers in acute cardiac care.
Chairs: Ola Hammarsten andChristian Löwbeer

15:15 - 15:45 Copeptin—Marker of Acute Myocardial Infarction (215)
Martin Möckel, Germany

15:45 - 16:15 PEA multiplex technology – New tools for clinical proteomics (216)
Agneta Siegbahn, Sweden

16:15 - 16:30 A Multi-Center Analytical Evaluation of the ARCHITECT STAT High Sensitive Troponin-I Assay (217)
Lieselotte Lennartz, Germany

16:30 - 16:45 Highly Multiplexed Proteomic Analysis as a translational tool: Implications for useful biomarker discovery and early clinical development. (218)
Stephen Williams, United States

Room: F2

The Astrup Prize

The Astrup Prize is awarded to contemporary Nordic research work related to the field of clinical chemistry. The Prize is sponsored by Siemens.

The winners of the Astrup prizes will be announced at the Congress Banquet.

Chair: Lars Melholt Rasmussen

15:15 - 15:35 The soluble mannose receptor
Sidsel Rødgaard-Hansen, Denmark

15:35 - 15:55 Comparing the diagnostic accuracies of CSF Aβ42 and PET Florbetapir
Niklas Mattson,Sweden

15:55 - 16:15 Detection of polymerized C1-inh in plasma of HAE patients – possible role in contact activation
Daniel Elenius Madsen, Denmark

Room: F3

Next Generation Sequencing (NGS) in clinicaldiagnosis

Next Generation Sequencing has revolutionised gene sequencing by allowing the simultaneous analysis of multiple genes, and has been optimised to such an extent that it is now possible to apply it to clinical diagnoses. In this session we willpresent some examples of how NGS has contributed to the identification of new gene defects linked to hereditary human diseases.

Chair: Jorge Asin Cayuela and Anne Ricksten

15:15 - 15:40 Next generation sequencing in the identification of new pathogenic mechanisms for mitochondrial disorders (219)
Henna Tyynismaa, Finland

15:40 - 16:05 Next Generation Sequencing in Inherited Cardiovascular Diseases (220)
Lorenzo Monserrat, Spain

16:05 - 16:30 Genomic analysis of Neurodegenerative Disease (221)
John Hardy, United Kingdom

16:30 - 16:45 Pilot study for the detection of mutations associated with lysosomal diseases using Next Generation Sequencing (222)
Julia Lindgren, Sweden

16:45- 17:00 The use of design programs from Sequenom when diagnosing familial hypercholesterolemia (223)
Peter Benedek, Sweden



SKKLF Annual Meeting - Room: Nordenskiöld

SSKF Annual Meeting - Room: F2

Possibility for companies to arrange a social sponsor activity